Minimize Turnaround and Maximize Clinical Utility with PierianDx Clinical Genomics Workspace™
Please log in for more information
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Founded in 2014 out of Washington University in St. Louis, Pierian is focused on advancing cancer diagnostics and making targeted therapeutics more accessible to healthcare systems, laboratories, and patients worldwide. Its industry-leading clinical genomics technologies, CAP and CLIA accredited laboratory, IVD-ready knowledgebase and reporting solution, and expertise deliver the most integrated, trusted, and collaborative approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, Pierian drives the adoption of genomics in clinical care and accelerates the fight against cancer and other diseases.